Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial

Doyle, Mittie K., Rahman, Mahboob U., Frederick, Bart · Rheumatology · 2013